Oct 20 (Reuters) - Global drugmakers are rushing to boost U.S. manufacturing and inventory as the Trump administration weighs a 100% tariff on imported branded and patented drugs. Although enforcement ...
Every time Brent D. Griffiths publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback